Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement
Akanda Corp. (NASDAQ: AKAN) has secured a hemp cultivation license in Canada, marking a significant milestone in its expansion strategy. This license is directly linked to Akanda's previously announced agreement with 1107385 B.C. , reinforcing the company's commitment to establishing a strong presence in the Canadian cannabis market. The development underscores Akanda's dedication to executing its strategic vision and solidifying its position as a global leader in the cannabis industry.
Akanda Corp. (NASDAQ: AKAN) ha ottenuto una licenza per la coltivazione di canapa in Canada, segnando un'importante pietra miliare nella sua strategia di espansione. Questa licenza è direttamente collegata all'accordo precedentemente annunciato con 1107385 B.C., rafforzando l'impegno dell'azienda a stabilire una solida presenza nel mercato canadese della cannabis. Questo sviluppo sottolinea la dedizione di Akanda nell'eseguire la sua visione strategica e nel consolidare la sua posizione come leader globale nell'industria della cannabis.
Akanda Corp. (NASDAQ: AKAN) ha obtenido una licencia para el cultivo de cáñamo en Canadá, marcando un hito significativo en su estrategia de expansión. Esta licencia está directamente vinculada al acuerdo previamente anunciado con 1107385 B.C., reafirmando el compromiso de la empresa de establecer una fuerte presencia en el mercado canadiense de cannabis. Este desarrollo subraya la dedicación de Akanda en ejecutar su visión estratégica y consolidar su posición como líder global en la industria del cannabis.
아칸다 코퍼레이션 (NASDAQ: AKAN)이 캐나다에서의 대마 재배 라이센스를 확보하여 확장 전략의 중요한 이정표를 세웠습니다. 이 라이센스는 아칸다가 이전에 발표한 1107385 B.C.와의 계약과 직접 연결되어 있으며, 캐나다 대마 시장에서의 강력한 입지를 구축하려는 회사의 의지를 강화합니다. 이번 발전은 아칸다가 전략적 비전을 실행하고 대마 산업의 글로벌 리더로서의 위치를 확고히 하려는 헌신을 강조합니다.
Akanda Corp. (NASDAQ: AKAN) a obtenu une licence de culture de chanvre au Canada, marquant une étape importante dans sa stratégie d'expansion. Cette licence est directement liée à l'accord précédemment annoncé avec 1107385 B.C., renforçant l'engagement de l'entreprise à établir une forte présence sur le marché canadien du cannabis. Ce développement souligne le dévouement d'Akanda à exécuter sa vision stratégique et à consolider sa position en tant que leader mondial dans l'industrie du cannabis.
Akanda Corp. (NASDAQ: AKAN) hat eine Lizenz zur Hanfanbau in Kanada gesichert, was einen bedeutenden Meilenstein in seiner Expansionsstrategie darstellt. Diese Lizenz steht in direktem Zusammenhang mit der zuvor bekannt gegebenen Vereinbarung mit 1107385 B.C., was das Engagement des Unternehmens zur Schaffung einer starken Präsenz im kanadischen Cannabismarkt unterstreicht. Diese Entwicklung betont Akandas Engagement, seine strategische Vision umzusetzen und seine Position als weltweiter Marktführer in der Cannabisindustrie zu festigen.
- Obtained hemp cultivation license in Canada
- Advances strategic initiatives in Canadian cannabis market
- Builds on previous development agreement with 1107385 B.C.
- None.
London, United Kingdom--(Newsfile Corp. - September 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), a global cannabis company, is excited to announce that it has obtained a license for hemp cultivation in Canada. This license is directly tied to Akanda's previously announced agreement with 1107385 B.C. LTD, further advancing the company's strategic initiatives in the Canadian cannabis market.
This latest development highlights Akanda's commitment to executing its strategic vision and solidifying its role as a leader in the global cannabis industry.
About Akanda Corp.
Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.
Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram
Investor Contact
ir@akandacorp.com
Cautionary Note Regarding Forward-Looking Information and Statements
This press release contains certain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking statements may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/223482
FAQ
What new license has Akanda Corp. (AKAN) obtained in Canada?
How does the new license relate to Akanda's previous agreements?
What market is Akanda Corp. (AKAN) targeting with this new license?
When did Akanda Corp. (AKAN) announce obtaining the hemp cultivation license?
